Illumina (NSDQ:ILMN) announced today that it entered into an agreement to acquire Grail for cash and stock consideration of $8 billion. Last week, it was reported that Illumina was looking to purchase the cancer detection startup that spun out from the company four years ago and the companies confirmed that to be true today. Grail was […]
Philips launches lung cancer diagnosis, treatment platform
Royal Philips (NYSE:PHG) announced today that it launched the Azurion Lung Edition imaging system for diagnosing and treating lung cancer. Amsterdam-based Philips’ Azurion Lung Edition is a 3D-imaging and navigation platform for accelerating lung cancer diagnosis and treatment by combining CT-like 3D images acquired at the tableside with live X-ray guidance and other tools to support […]
Varian wins FDA clearance for cancer therapy software
Varian Medical Systems (NYSE:VAR) announced that it received FDA 510(k) clearance for its Eclipse v16.1 treatment planning software. Palo Alto, Calif.-based Varian’s Eclipse V16.1 software is designed to enhance the visibility of soft tissue and provide more accurate information about tissue density, allowing dosimetrists to plan more precisely as they go about performing proton therapy, according […]
Varian names new president & COO among other personnel changes
Varian Medical Systems (NYSE:VAR) today announced a trio of personnel changes including the appointment of a new president and COO. Effective Oct. 5, 2020, current Varian Oncology Systems president Chris Toth will take over the newly created roll of president and COO. As a result, current senior VP of global operations Kevin O’Reilly will take over […]
Bruker acquires Canopy Biosciences
Bruker Corp. (NSDQ:BRKR) announced today that it acquired biomarker imaging technology developer Canopy Biosciences. Billerica, Mass.-based Bruker said in a news release that the acquisition, for which financial details were not disclosed, enhances its offering in targeted multi-omics and fluorescence-based imaging technologies and combines its global reach with Canopy’s success to date. Canopy develops high multiplex […]
FDA: Thousands of new breast-implant-related illnesses reported
The FDA today reported that it has received nearly 2,500 new reports globally of “breast implant illness” or BII. Reports of new breast implant-related cancer were also up. BII is not cancer, nor is it a term often found in medical literature, the agency said. But it is frequently used by patients and healthcare providers […]
Siemens Healthineers to buy Varian for $16.4b
Siemens Healthineers (ETR: SHL) will acquire Varian Medical Systems (NYSE:VAR) in a $16.4 billion deal to create what the companies say will be the most comprehensive cancer care portfolio in the industry. SHL shares closed down –8.95% to €40.02 apiece in trading in Germany today, while VAR shares are up 21.61% to $173.57 apiece as of midday NYSE […]
Hologic blasts American Cancer Society over new Pap test guidelines
Hologic (NSDQ:HOLX) — a major company in the Pap and human papillomavirus (HPV) testing space — is criticizing the American Cancer Society over new cervical cancer screening recommendations that prefer simply doing HPV tests every five years. “Although all the screening tests are good at finding cancer and pre-cancer, primary HPV testing is better at finding […]
The most innovative pharmaceutical agents of 2020
The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, […]
J&J’s Ethicon wins FDA breakthrough nod for microwave ablation tech
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon announced that it received FDA breakthrough device designation for its microwave ablation technology. The transbronchial microwave ablation technology, which is currently under development, utilizes robotic-assisted bronchoscopy. Johnson & Johnson’s acquisitions of NeuWave Medical and Auris Health allowed the company to bring the robotic surgical and microwave ablation technology together to […]
DTW: What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical […]
- 1
- 2
- 3
- …
- 83
- Next Page »
